The FAR Council explained that FAR Part 4: has been reorganized within each subpart to follow the acquisition process (i.e., steps to take before solicitation versus after award). This new structure ...
A multi-purpose biopharmaceutical manufacturing facility using a matrix of multi-functional cleanrooms can be adapted to efficiently meet the capacity challenges of both supplying clinical trials and ...
The biopharmaceutical industry must begin designing and building a new generation of highly capable, multi-purpose manufacturing facilities to meet the commercial manufacturing challenges of supplying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results